319 E. Madison Street
About Rational VaccinesRational Vaccines was formed in 2015 for the purpose of offering better solutions to stop the spread of herpes and alleviate the problems faced by people suffering with unrelenting, chronic disease.
Founder and CEO: Agustin Fernandez (III)
Founder and CSO: William Halford PhD
15 articles with Rational Vaccines
Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus
Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the launch of a clinical trial designed to determine the baseline characteristics of patients diagnosed with recurrent symptomatic herpes simplex virus type 2 (HSV-2).
Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.
Rational Vaccines, today announced preclinical research suggesting that the Company's herpes simplex virus type 1 (HSV-1) vaccine candidate can protect against herpetic keratitis (HK), a leading infectious cause of blindness in developed countries.
Rational Vaccines Announces a Clinical Study of the Frequency of Symptomatic Herpes Simplex Type 1 and 2 (HSV-1 and HSV-2) Virus in HIV Patients
Rational Vaccines today announced the launch of a clinical trial designed to investigate the disease burden of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in patients with HIV infection.
Rational Vaccines Announces the Appointment of Kerstin Westritschnig, MD, as Chief Medical Officer (CMO)
Rational Vaccines today announced the appointment of Kerstin Westritschnig, MD, as the Company's chief medical officer (CMO).
A vaccine for herpes is under development and Rational Vaccines are going to make this a reality very soon. Here's everything you need to learn about it.
Two novel vaccine candidates for the prevention and treatment of genital herpes have shown to be safe in pre-clinical animal studies according to a study published in the journal Vaccines.
By 1999 Dr. Konstantin 'Gus' Kousoulas was a tenured professor and consultant. While he wasn't extremely wealthy, he considered himself successful and satisfied with where life was going.
Rational Vaccines, a vaccine biotech firm based in Cambridge, Mass., points to the proven science of live-attenuated viruses in vaccine development as key to the company's commitment to the development platform.
Rational Vaccines, a live-attenuated vaccine biotech firm based in Cambridge, Mass., announced the launch of its new website, https://rationalvaccines.com/.
4/12/2018One month after three patients who developed adverse reactions following injections of an unauthorized herpes vaccine filed a lawsuit against Rational Vaccines, the U.S. Food and Drug Administration has launched a criminal investigation into the matter.
Rational Vaccines Release: First Ever Human Trial Of A Live Attenuated Functioning Therapeutic Herpes Vaccine